MSH|^~\&|MVA-BSLAB|SMH|FFC|FFC|20220206222619||ORU^R01|0207LAB01|T|2.4
PID|1||123456789||TEST^SALLY||20010112|F||||||||||700000000001|229893431
PV1|1|OP|C1952^1114-0||||08584|||||||||||OP||||||||||||||||||||||||||202202060000|
ORC|RE|0207LAB01A||0|||||20220206222619|||08584^WALLER^RACHEL^^||||^
OBR|1|0207LAB01A||MP^METABOLIC PANEL, COMP|||20220205210000|||666555^TECH1^TEST T - MRSS^^||||20220206214300|^^|8584^WALLER^RACHEL^^||||W2941166|||||F||^^^^^S||||||
OBX|1|NM|NA^SODIUM|1|142|MMOL/L|136-145||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|2|NM|K^POTASSIUM|1|3.5|MMOL/L|3.5-5.1||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|3|NM|CL^CHLORIDE|1|108|MMOL/L|97-108||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|4|NM|CO2^CO2|1|30|MMOL/L|21-32||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|5|NM|AGAP^ANION GAP|1|4|mmol/L|5-15|L|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|6|NM|GLU^GLUCOSE|1|127|MG/DL|65-100|H|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|7|NM|BUN^BUN|1|21|MG/DL|6-20|H|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|8|NM|CREA^CREATININE|1|1.33|MG/DL|0.45-1.15|H|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|8|CE|CREA^CREATININE|2|** Note new reference range and method **||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|9|NM|BUCR^BUN/CREATININE RATIO|1|16||12-20||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|10|ST|GFRAA^GFRAA|1|>60|ml/min/1.73m2|>60||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|NM|GFRNA^GFRNA|1|52|ml/min/1.73m2|>60|L|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|2|Estimated GFR is calculated using the IDMS-traceable Modification of Diet in||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|3| Renal Disease (MDRD) Study equation, reported for both African Americans||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|4| (GFRAA) and non-African Americans (GFRNA), and normalized to 1.73m2 body||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|5| surface area. The physician must decide which value applies to the patient.||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|6|The MDRD study equation should only be used in individuals age 18 or older. It||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|7| has not been validated for the following: pregnant women, patients with serious||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|8| comorbid conditions, or on certain medications, or persons with extremes of||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|11|CE|GFRNA^GFRNA|9| body size, muscle mass, or nutritional status.||||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|12|NM|CA^CALCIUM|1|8.9|MG/DL|8.5-10.1||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|13|NM|TBIL^BILIRUBIN,TOTAL|1|0.3|MG/DL|0.2-1.0||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|14|NM|GPT^ALT|1|16|U/L|12-78||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|15|NM|SGOT^AST|1|15|U/L|15-37||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|16|NM|AP^ALK PHOS|1|74|U/L|50-136||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|17|NM|TP^PROTEIN, TOTAL|1|7.1|g/dL|6.4-8.2||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|18|NM|ALB^ALBUMIN|1|3.4|g/dL|3.5-5.0|L|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|19|NM|GLOB^GLOBULIN|1|3.7|g/dL|2.0-4.0||||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM
OBX|20|NM|AGRAT^A-G RATIO|1|0.9| |1.1-2.2|L|||F|||202202062226|MRMC1^MEMORIAL REGIO|5555^SMITH^TEST R - MRM